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ABSTRACT Our mathematical model of the rat ventricular myocyte (Pandit et al., 2001) was utilized to explore the ionic
mechanism(s) that underlie the altered electrophysiological characteristics associated with the short-term model of
streptozotocin-induced, type-I diabetes. The simulations show that the observed reductions in the Ca2þ-independent transient
outward Kþ current (It) and the steady-state outward K
þ current (Iss), along with slowed inactivation of the L-type Ca
2þ current
(ICaL), can result in the prolongation of the action potential duration, a well-known experimental ﬁnding. In addition, the model
demonstrates that the slowed reactivation kinetics of It in diabetic myocytes can account for the more pronounced rate-
dependent action potential duration prolongation in diabetes, and that a decrease in the electrogenic Naþ-Kþ pump current
(INaK) results in a small depolarization in the resting membrane potential (Vrest). This depolarization reduces the availability of
the Naþ channels (INa), thereby resulting in a slower upstroke (dV/dtmax) of the diabetic action potential. Additional simulations
suggest that a reduction in the magnitude of ICaL, in combination with impaired sarcoplasmic reticulum uptake can lead to
a decreased sarcoplasmic reticulum Ca2þ load. These factors contribute to characteristic abnormal [Ca2þ]i homeostasis
(reduced peak systolic value and rate of decay) in myocytes from diabetic animals. In combination, these simulation results
provide novel information and integrative insights concerning plausible ionic mechanisms for the observed changes in cardiac
repolarization and excitation-contraction coupling in rat ventricular myocytes in the setting of streptozotocin-induced, type-I
diabetes.
INTRODUCTION
Cardiovascular complications arising from diabetes mellitus
are a leading cause of morbidity and mortality (Dillmann,
1989; Standl and Schnell, 2000). In addition to an increased
incidence of coronary artery disease, the electrophysiologi-
cal and the mechanical properties of the myocardium are
significantly impaired (Dillmann, 1989; Mahgoub and Abd-
elfattah, 1998). The rat constitutes a widely utilized experi-
mental model used to study the effects of diabetes on the
heart. In an acute model of type-I (insulin deficient) dia-
betes, rats are injected with streptozotocin (STZ) (100 mg/kg
of body wt.), and then sacrificed 4–6 days after treatment
(Shimoni et al., 1994; 1995). Rat ventricular myocytes from
this short-term diabetic model exhibit a prolongation of the
action potential duration (APD) (Shimoni et al., 1994; 1995),
along with altered intracellular Ca2þ homeostasis, depicted
by a small reduction in the peak systolic value, and a slower
decay of the intracellular Ca2þ transient ([Ca2þ]i) (Ren and
Davidoff, 1997). The marked delay in the final repolarization
of the action potential may be responsible for the observed
lengthening of the QT interval in diabetic patients (Robillon
et al., 1999), and this can contribute to the enhanced incidence
of cardiac arrhythmias (Ewing et al., 1991). It is therefore
important to understand the ionic mechanism(s) that underlie
the altered repolarization and the excitation-contraction
(E-C) coupling associated with the short-term, type-I,
model of diabetes, and to gain quantitative insights into the
relationship between these variables.
Experimental studies have shown that injecting STZ
results in a reduction in the densities of both the Ca2þ-
independent transient outward Kþ current (It), and the
steady-state outward Kþ current (Iss) (Shimoni et al., 1994;
1995). The subsequent decrease in the net repolarizing
current is responsible for the prolongation of the APD
(Shimoni et al., 1994; 1995). In contrast, the subcellular
mechanisms responsible for the abnormal [Ca2þ]i behavior
in the short-term diabetic model are not understood, although
it is believed that dysfunction associated with the uptake
of Ca2þ into the sarcoplasmic reticulum (SR) is responsible
(Ren and Davidoff, 1997). Recently it was reported that
freshly isolated normal adult rat ventricular myocytes
maintained under cell culture conditions with hypoinsuline-
mia and hyperglycemia developed a phenotype (prolonged
APD, slower [Ca2þ]i decay), somewhat similar to the one
that has been described for myocytes isolated from the in
vivo, short-term diabetic model (Davidoff and Ren, 1997;
Ren et al., 1997). Hyperglycemic culture conditions are
known to activate protein kinase C (PKC). More specifically,
the e isoform of PKC (ePKC) is activated and translocated to
the sarcolemma (Malhotra et al., 2001). ePKC is the major
PKC isoform in the adult rat ventricle (Bogoyevitch et al.,
1993; Rybin and Steinberg, 1994). Activation of ePKC not
only modulates It and Iss (Shimoni, 1999), as is observed in
the in vivo diabetic model (Shimoni et al., 1994; 1995), but
has also been shown to downregulate the densities of the
L-type Ca2þ current (ICaL) (Hu et al., 2000), and the Naþ-Kþ
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pump current (INaK) (Buhagiar et al., 2001). Results from the
available experimental studies therefore suggest that multi-
ple interdependent ionic mechanisms (It, Iss, ICaL, INaK, and
SR uptake) can mediate the electrophysiological alterations
associated with this acute, type-I model of diabetes.
One approach for obtaining novel, semiquantitative
insights into the complex, nonlinear interactions between
different ionic mechanisms in cardiac electrophysiology is
to utilize mathematical models that are based closely on
experimental findings. In this way the cardiac action po-
tential can be reconstructed, based on detailed biophysical
formulations of the underlying ionic currents, pumps, and
exchangers (Rudy, 2000; Winslow et al., 2000; Noble,
2002). Recently, we have developed a comprehensive
mathematical model for the cardiac action potential of adult
rat ventricular myocytes (Pandit et al., 2001). The equations
in this model were based on biophysically derived de-
scriptors of experimentally recorded ionic currents, pumps,
and the Naþ-Ca2þ exchanger (INaCa) in myocytes isolated
from the adult rat ventricle. The descriptions for the Ca2þ
homeostasis mechanisms (dynamics and buffering) in the
rat model were adapted (with minimal modifications) from
a recent publication of Ca2þ handling in the canine mid-
myocardial cell (Winslow et al., 1999).
The main goal of the present study was to develop
a mathematical representation of the diabetic phenotype by
incorporating changes in the ionic mechanisms that are sug-
gested by experimental data to underlie the altered electro-
physiological characteristics in the short-term, type-I model
of STZ-induced diabetes. The model is able to qualita-
tively simulate the prolongation of the APD in accordance
with experimental results (Fig. 1). Moreover, it provides
novel insights into the ionic basis for this change in the action
potential profile during diabetic conditions, and illustrates
the complex, nonlinear relationship between the APD and
both intracellular Ca2þ homeostasis, and E-C coupling.
METHODS
Mathematical model of the rat
right ventricular myocyte
A mathematical model of the adult rat right ventricular (RV) cell was
employed in all simulations because myocytes isolated from the RV have
been utilized in most available experimental studies (Shimoni et al., 1994).
This model was derived from a recently published left ventricular (LV)
epicardial cell model (Pandit et al., 2001) by making modifications to the
following ionic currents:
INa
The density of INa was increased by 33%. This was based on recent
experimental findings, which reported a variation in the density of INa in the
rat ventricle, with higher expression in RV myocytes, compared with those
from the LV epicardial ones (Ashamalla et al., 2001).
It
The density of It was increased by 25%, based on reported larger values of It
in rat RV myocytes than LV epicardium (Casis et al., 1998).
ICaL, Iss
The densities of both ICaL and Iss were increased by 10%, so that the influx
of Ca2þ ions via ICaL (QCaL), and the APD90 value during a simulated RV
action potential were comparable to corresponding experimental measure-
ments in rat RV myocytes (Kaprielian et al., 1999; MacDonell et al., 1998)
(See the Results section for a comparison of simulated and experimental
values in normal RV myocytes).
A model of the rat right ventricular cell
in the setting of type-I diabetes
The following modifications were made in the computational model of the
normal rat RV myocyte to represent the short-term, type-I diabetic myocyte.
It
The density of It was decreased by 32%. The formulation of It also consists
of fast and slow inactivation variables, with the relative contribution of the
slow variable to overall inactivation being 11% in the normal myocyte.
This was increased to 31% in the diabetic myocyte. Both of these changes
are based on experimental observations that the density of It is reduced, and
its reactivation kinetics is slower in diabetic ventricular myocytes (Shimoni
et al., 1994; 1995). The simulated current-voltage (I-V) relationship of It is
shown in Fig. 2 A, along with corresponding experimental data, which was
recorded in control and diabetic RV myocytes respectively (Shimoni et al.,
1994).
Iss
The density of Iss was decreased by 23%. Fig. 2 B illustrates the simulated
I-V characteristics for Iss in normal and diabetic rat RV myocytes, along
with experimental data (Shimoni et al., 1994).
ICaL
The density of ICaL was reduced by 24%. This was based on recent
experimental findings that the activation of ePKC in adult rat ventricular
FIGURE 1 (A) Action potential waveforms for model generated control
(solid line) and diabetic (dashed line) action potentials. (B) Experimentally
recorded control (solid line) and diabetic (dashed line) action potentials at
1 Hz and 228C (Shimoni et al., 1994).
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myocytes reduces ICaL density by 27.96 2.2% (Hu et al., 2000). It has also
been shown recently that the fast inactivation time constant of ICaL is slowed
(by 40%) in the chronic model of diabetes (Chattou et al., 1999). The fast
inactivation time constant of ICal in our model was therefore reduced by
10%, to represent the acute diabetic conditions.
INaK
It is well-known that the Naþ-Kþ-ATPase activity is decreased in STZ-
induced diabetic rats (Kato et al., 1999). This was incorporated in the
diabetic model by reducing the maximum density of INaK by 37%. This was
based on the reported effects of ePKC on INaK density measured in rabbit
ventricular myocytes (Buhagiar et al., 2001).
The changes in ICaL and INaK were incorporated based on the observation
that ePKC is activated and then translocated to the sarcolemmal membrane in
cultured rat ventricularmyocytesmaintained under high extracellular glucose
concentrations of 25.0 mM (Malhotra et al., 2001). This glucose level is
similar to the plasma glucose concentrations recorded in the short-term, type-
I, in vivomodel of diabetes in rat, viz. 26.36 2.15mM (Shimoni et al., 1994).
IBCa, IBNa
The steady or background Ca2þ current (IBCa) was reduced by 50% in the
diabetic myocyte. This was done to maintain almost identical values of
diastolic [Ca2þ]i during both control and diabetic simulations, in accordance
with experimental findings (Ren and Davidoff, 1997). The peak magnitude
of IBCa during resting conditions in the control myocyte is very small (5
pA). Therefore the 50% reduction in IBCa will not affect the action potential
duration significantly in diabetes. Nevertheless, to compensate for a reduc-
tion of IBCa, the Naþ background current (IBNa) conductance was increased
by 25% in the diabetic myocyte, so that the total background current (IB) in
the range of membrane potentials near rest in both control and diabetic
simulations was almost identical.
SR Ca21-ATPase
Although defects in the SR mechanisms have been well-studied in the
chronic model of diabetes (Netticadan et al., 2001), very little quantitative
information is available regarding these alterations in the acute model of
diabetes (Ren and Davidoff, 1997). A recent study has shown that the
SERCA2a protein density is decreased by 60% in a chronic model of
diabetes (Netticadan et al., 2001). Similarly, it is known that the affinity of
Ca2þ ions to the SR pump is also reduced in chronic diabetes (Zhong et al.,
2001). Based on these observations in the chronic model of diabetes, it has
been postulated that defects in the uptake of Ca2þ ions into the SR also
underlie the abnormal [Ca2þ]i behavior in short-term diabetes (Ren and
Davidoff, 1997). The SR Ca2þ-ATPase scaling factor (KSR) in the RV
computational model was reduced by 45%, and the Ca2þ-ATPase forward
rate parameter (vmaxf) was reduced by 20%, to represent the overall
impairment in the refilling of the SR, and simulate an altered [Ca2þ]i similar
to the one observed experimentally in short-term diabetes.
Other assumptions
The membrane capacitance (Cm) was assigned the same value (100 pF) in
the control and the diabetic cell models, consistent with experimental
findings (Shimoni et al., 1994). It has been recently reported that the function
of the Naþ-Ca2þ exchanger (INaCa) is not altered in rat ventricular myocytes
cultured under high glucose conditions (Dutta and Davidoff, 2000).
Therefore the parameters for INaCa were similar in the control and diabetic
model formulations. All other ionic mechanisms, as well as the parameters
describing the SR Ca2þ handling were assumed to be identical in the control
and the diabetic models. The extracellular ionic concentrations in both the
models were assumed to be constant, and all simulations were carried out at
an assumed temperature of 228C, conditions under which most of the
experimental data were recorded.
Computational aspects
The mathematical model was implemented in C, on a SUN Microsystem
Sparc Ultra 60 workstation. A Runge-Kutta-Merson numerical integration
algorithm, which includes an automatic step-size adjustment that is based on
an error estimate, was used for the whole-cell simulations, as in our previous
model studies (Demir et al., 1994, 1997, 1999; Pandit et al., 2001). The
software package Matlab was also utilized in formulating model equations
for the ionic channels. All the results are presented in their steady state,
which was defined as the action potential obtained after allowing the model
to run for 20 s after a change in the initial conditions. This approach is in
accordance with earlier modeling studies examining changes in action
potential and [Ca2þ]i profiles in pathophysiological conditions such as heart
failure (Winslow et al., 1999) and atrial fibrillation (Courtemanche et al.,
1999). This ensures rapid rate adaptation of the action potential, but does not
take into account the long-term effects in the changes in the intracellular
ionic concentrations (Courtemanche et al., 1999). The rat model requires
FIGURE 2 (A) Simulated current-voltage (I-V) relationship for the Ca2þ-
independent transient outward Kþ current It in control (, solid line) and
diabetic (, dashed line) myocytes, which were isolated from the adult rat
right ventricle (,  represent experimental data from Shimoni et al., 1994).
(B) Simulated current-voltage (I-V) relationship for the steady-state outward
Kþ current Iss in control (, solid line) and diabetic (, dashed line)
myocytes, which were isolated from the adult rat right ventricle (, 
represent experimental data from Shimoni et al., 1994).
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a run time of ;10 min on the present computing platform to simulate
a steady-state action potential.
RESULTS
Action potential waveforms and underlying
ionic currents in control and diabetic
ventricular myocytes
A stimulus of 0.6 nAwas applied for 5ms, in accordance with
experimental protocols (Ward et al., 1997), to generate the
simulated control and diabetic action potentials at a frequency
of 1.0 Hz and an assumed temperature of 228C. (Fig. 1 A).
The effects of the intracellular Ca2þ buffer EGTA in the
recording pipette were included in the model in accordance
with an earlier formulation (Winslow et al., 1999), because
EGTA is used in majority of the electrophysiological ex-
periments of this kind (Shimoni et al., 1994). A set of ex-
perimentally recorded action potentials under control and
diabetic conditions (Shimoni et al., 1994) are shown in Fig. 1
B. The simulated control RV action potential closely
resembles its experimental counterpart (Fig. 1). The simu-
lated diabetic APD is larger than the corresponding control
counterpart (Fig. 1 A) in accordance with experimental
results (Fig. 1 B). However, the experimentally recorded
diabetic action potential exhibits a larger prolongation (Fig. 1
B) than seen in simulations (Fig. 1 A). A quantitative
comparison between the simulated and experimental diabetic
action potentials was not attempted mainly because of the
reportedly large variations in the duration and the shape of
experimentally recorded diabetic action potentials, despite
similar isolation procedures and recording conditions (e.g.,
see Fig. 1, B andC, in Shimoni et al., 1994). In particular, the
APD90 value varies considerably in individual diabetic cells
over time, and from cell to cell (Shimoni et al., 1998). This
could be the result of variations in the magnitudes of the Kþ
or background currents in diabetes (Shimoni et al., 1998), or
due to the enhancement of the intrinsic action potential
heterogeneity, in the rat ventricular myocardium (Watanabe
et al., 1983; Ward and Giles, 1997). For these reasons, the
emphasis in this modeling study was on determining whether
the simulated diabetic action potential could qualitatively
reproduce the experimentally observed action potential
changes resulting from STZ-induced diabetes. A similar
approach was successfully employed in our previous
simulations, which compared and contrasted epicardial and
endocardial action potentials in adult rat left ventricular
myocytes (Pandit et al., 2001).
The simulated control and diabetic action potential
characteristics are compared in detail in Table 1. Parameters
for the simulated control RV action potential (Table 1) are
very close to the corresponding experimental measurements
from control myocytes, which were 80.15 6 0.79 mV
(Vrest), 205.66 11.8 V/s (dV/dtmax), 40.946 1.26 mV (peak
overshoot), 33.27 6 5.31 ms (APD90) (All measurements
from MacDonell et al., 1998); and 62.8 6 28.3 MV (Rin)
(Shimoni et al., 1994). Vrest, Rin, and peak overshoot have
similar values in the simulated control and diabetic action
potentials, whereas the APD50 and APD90 are larger in the
diabetic action potential; this is in qualitative agreement with
experimental observations (Shimoni et al., 1994). In fact,
even the small depolarization in Vrest (by 0.55 mV), and
a small increase in Rin (by 0.31 MV) in the simulated
diabetic action potential agree with the experimental
observation that ‘‘the passive properties of diabetic cells
were not significantly different from those of the normal
cells, although there was a tendency toward a slight
depolarization of the resting potential and an increase in
input resistance’’ (Shimoni et al., 1994). Our model also
exhibits a small reduction in dV/dtmax during the diabetic
action potential (decreased by 5.05%), with respect to the
control value.
Rate-dependent changes of the simulated cardiac action
potentials at frequencies of 0.5 Hz and 2.0 Hz, in both
control and diabetic cases, are shown in Fig. 3 A and B,
respectively. When the stimulation rate was increased from
0.5 Hz to 2.0 Hz, the APD prolongation was more
pronounced in the diabetic conditions. This agrees with
experimental observations (Shimoni et al., 1994). The time-
and voltage-dependent currents that primarily determine the
plateau phase of the cardiac action potential in rat ventricular
myocytes (It, ICaL, Iss) are shown in Fig. 4. Both It and ICaL
have smaller peak amplitudes in the diabetic case, whereas
the peak magnitude of Iss is almost unchanged. Overall, there
is a net reduction in the outward repolarizing current, lead-
ing to a prolongation of the APD. The alteration in the ICaL
waveform in diabetes (smaller magnitude, slower deactiva-
tion) has important implications for dynamic changes in
[Ca2þ]i, and is discussed in the next subsection. The Naþ-Kþ
pump and the Naþ-Ca2þ exchanger currents (INaK and INaCa,
respectively), the inward rectifier Kþ current (IK1), and the
background current (IB) underlying the simulated control
and diabetic action potentials are shown in Fig. 5. INaK is
reduced in the diabetic case. Note that IB and IK1 have an
altered profile; this difference between the control and
diabetic conditions is primarily due to the changed contour
of the action potential waveforms (the density of IK1 was
identical in the control and the diabetic models, IB is almost
similar in control and diabetic cases).
TABLE 1 Simulated action potential characteristics in
control and diabetic myocytes from the rat right ventricle
Vrest
(mV)
Rin
(MV)
dV/dtmax
(V/s)
PO
(mV)
APD50
(ms)
APD90
(ms)
Control 80.48 71.25 182.97 41.63 14.29 31.11
Diabetic 79.93 71.56 173.73 42.10 22.50 48.86
Vrest: resting membrane potential; Rin: input resistance; dV/dtmax: max-
imum upstroke velocity; PO: peak overshoot; APD50: action potential
duration (50% repolarization); APD90: action potential duration (90%
repolarization).
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[Ca21]i and associated ﬂuxes in control
and diabetic cells
The simulated [Ca2þ]i waveforms corresponding to the
control and diabetic action potentials are shown in Fig. 6.
The diastolic and the peak systolic values of [Ca2þ]i during
the simulated control RV action potential (73.34 nM and
330.83 nM) were comparable to corresponding experimental
measurements in control RV myocytes, viz. 78.46 22.6 nM
and 401 6 115.0 nM respectively (Kaprielian et al., 1999).
The peak systolic value of the simulated [Ca2þ]i is reduced
by 5% in the diabetic case (Table 2), although the diastolic
values were similar (73 nM). This reduction in the peak
systolic [Ca2þ]i is in accordance with experimental obser-
vations, where the mean peak Ca2þ ratio (measurements
made using Fura-2) in the diabetic cells was reduced by
10.0% (Ren and Davidoff, 1997). The simulated Ca2þ
transient declines more slowly in the diabetic case, as
demonstrated in experimental observations (Ren and David-
off, 1997). The alterations in the ICaL waveform result in
a higher influx of Ca2þ ions (QCaL) during the diabetic action
potential, compared to the control one (exact values were
15.63 pC and 12.24 pC respectively). QCaL value for the RV
myocyte in the control case is in close agreement with the
experimental measurement, 12.46 1.7 pC (Kaprielian et al.,
1999). The net influx of Ca2þions (via ICaL and IBca) during
an action potential in both the control and diabetic cases is
balanced by the Ca2þ extrusion via INaCa during a cardiac
cycle (Table 2). This is in accordance with experimental
findings regarding the balance of Ca2þ ion transfer across the
sarcolemma during a cardiac cycle (Bouchard et al., 1995;
Clark et al., 1996). The Ca2þ content in the junctional SR
(JSR) just before the application of a stimulus to elicit
a simulated action potential in the control RV myocyte
was 60.24 mM; this is similar to the recently reported
physiological values of SR Ca2þ content in rat ventricular
myocytes, which were 64.06 6.0 mM (Trafford et al., 2001)
and 56 6 7.2 mM (Sah et al., 2001). The JSR Ca2þ content
was reduced by 26.38% during the diabetic action potential
(the absolute value was 44.35 mM). However, the depletion
of the JSR during both control and diabetes actions
potentials was comparable; JSR was depleted by 36%
and 39% during control and diabetic action potentials
respectively.
DISCUSSION
The main motivation for the development of this model was
to gain further quantitative insights concerning the ionic
basis of the impaired excitation, repolarization, and E-C
coupling processes in myocytes isolated from the ventricle
of adult rats exhibiting STZ-induced type-I diabetes. To
achieve this, we first derived and validated an approach for
simulating the electrophysiological responses and E-C
FIGURE 3 Rate dependence of simulated action potentials. (A) Steady-
state effects of applying stimuli on the control action potential at 0.5 Hz
(solid line) and 2.0 Hz (dashed line). (B) Steady-state effects of applying
stimuli on the diabetic action potentials at 0.5 Hz (solid line) and 2.0 Hz
(dashed line).
FIGURE 4 (A) Simulated action potentials, (B) underlying Ca2þ-in-
dependent transient outward Kþ current (It), and the L-type Ca2þ current
(ICaL), and (C) the steady-state outward Kþ current (Iss) during the control
(solid line) and diabetic (dashed line) conditions.
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coupling for the normal or control rat RV myocyte. This
formulation was then modified to mimic the electrophysio-
logical changes reported for the type-I model of diabetes.
The majority of these changes were based on semiquanti-
tative data obtained from patch clamp experiments in STZ-
induced diabetic myocytes, or observations in cultured
myocytes maintained under hyperglycemic conditions.
These were complemented with assumptions based on
measurements made in chronic diabetic conditions (when
data in acute diabetic conditions was unavailable). The
resulting simulations were able to mathematically recon-
struct a variety of the electrophysiological changes, which
are consistent features of diabetic myocytes. These include:
an increased APD, more pronounced rate-dependent APD
prolongation, slower dV/dtmax, abnormal [Ca2þ]i homeosta-
sis, as well as the small changes in the properties of the
quiescent cells (Vrest, Rin). Our computations illustrate how
the diabetic phenotype can result from concomitant changes
and complex nonlinear interactions between a number of
ion-channel currents (It, Iss, ICaL, IB, INa), and currents due to
the antiporter/pump (INaCa, INaK), and SR mechanisms (SR
uptake and load).
Action potential duration and inotropy
in diabetes
Initial investigations into the ionic basis of the delayed
repolarization in myocytes isolated from the short-term,
type-I diabetic model in rats showed that the densities of It
and Iss were reduced (Shimoni et al., 1994; 1995). Recent
investigations employing molecular biology techniques have
shown that the mRNA levels as well as the protein densities
of the Kþ channel a-subunits Kv4.2, Kv4.3, and Kv2.1 are
FIGURE 6 (A) Simulated action potentials, (B) underlying junctional
sarcoplasmic reticulum Ca2þ load ([Ca2þ]JSR), and (C) the underlying
intracellular Ca2þ transient ([Ca2þ]i) during control (solid line) and diabetic
(dashed line) conditions.
FIGURE 5 (A) Simulated action potentials, (B) underlying Naþ-Kþ
pump current (INaK), the Naþ-Ca2þ exchanger current (INaCa), and (C) the
background current (IB), and the inward rectifier Kþ current (IK1) during
control (solid line) and diabetic (dashed line) conditions.
TABLE 2 Simulated sarcolemmal and intracellular
calcium ﬂuxes in control and diabetic myocytes from the
rat right ventricle
QCaL
(pC)
QBCa
(pC)
QNaCa
(pC)
[Ca2þ]i,rest
(nM)
[Ca2þ]i,peak
(nM)
SRrest
(mM)
Control 12.24 4.66 16.07 73.34 330.83 60.24
Diabetic 15.63 2.3 16.96 73.13 316.14 44.35
QCaL: Calcium influx via ICaL during the action potential; QBCa: Calcium
influx via IB,Ca during the action potential; QNaCa: Calcium efflux via INaCa
during the action potential; [Ca2þ]i,rest: Diastolic value of [Ca2þ]i
[Ca2þ]i,peak: Peak systolic value of the Ca2þ transient during the action
potential; SRrest: JSR Ca2þ content during diastole.
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downregulated in this acute model of STZ-induced diabetes
in rats (Qin et al., 2001). Kv4.2/Kv4.3 a-subunits are
thought to encode for It (Fiset et al., 1997, Oudit et al., 2001);
whereas the Kv2.1 a-subunit along with other a-subunits
such as Kv1.5 and Kv3.1/Kv3.2 is thought to underlie the
TEA-sensitive Kþ current Iss in rat ventricular myocytes
(Nerbonne, 2001; Schultz et al., 2001).
In contrast, the role of changes in ICaL in the diabetic
phenotype remains poorly defined. Earlier experiments in
chronic diabetes reported no significant changes in ICaL
density (Jourdon and Feuvray, 1993); however, more recent
studies have suggested that the density of ICaL is down-
regulated (Wang et al., 1995; Chattou et al., 1999), and its
fast inactivation time constant is slowed (Chattou et al.,
1999). When the diabetic action potential in our model was
simulated assuming no changes in ICaL properties (not
shown), the APD was increased, but the model failed to
simulate the reported abnormal changes in [Ca2þ]i, despite
an impaired SR uptake. In fact, under these conditions/
assumptions, the peak systolic value of [Ca2þ]i was
enhanced. Further computational analyses showed that this
change in [Ca2þ]i was caused by the increase in APD, which
was so large (due to no reduction in the inward current ICaL),
that it led to a substantial enhancement of the influx of Ca2þ
ions via ICaL (increase by 100%), when compared to the
control case. This behavior is consistent with earlier
experimental results (Bouchard et al., 1995; Clark et al.,
1996), as well as recent model simulations (Pandit et al.,
2001), which demonstrated the mechanistic linkage between
an increased APD and increased influx of Ca2þ ions. The
increased influx was the basis of a larger trigger for calcium
induced calcium release (CICR), and subsequently increased
the efficiency of SR release (Pandit et al., 2001; Sah et al.,
2001), thereby compensating for the impaired SR uptake.
The end result was a higher peak systolic value for [Ca2þ]i.
However, when the diabetic action potential was simu-
lated by incorporating a reduced density and slower
inactivation kinetics of ICaL as well as an impaired SR
uptake, the model was able to simultaneously simulate an
increased APD and a small decrease in [Ca2þ]i amplitude.
For example, a reduction in ICaL density by 24% resulted in
a relatively smaller increase in the influx of Ca2þ ions during
the diabetic action potential (increase by 28%). This
smaller trigger for CICR, along with an impaired SR uptake,
resulted in the peak systolic value for [Ca2þ]i being
somewhat smaller during the diabetic action potential (Table
2), which is in accordance with experimental results (Ren
and Davidoff, 1997). A reduction in ICaL (an inward current)
will also tend to reduce the APD. However, because this
reduction was also accompanied by simultaneous reductions
in It and Iss, along with the slower inactivation of ICaL, the
net result was an overall reduction in the outward
repolarizing current, thereby prolonging the APD.
Our simulations thus support the hypothesis that changes
in the properties of ICaL are essential in explaining the
diabetic phenotype (increased APD, reduced [Ca2þ]i), and
draw attention to the intricate nonlinear interaction between
It, Iss, ICaL, and SR uptake, which brings about this change.
Rate dependence, excitation, and quiescent
properties of ventricular myocytes
in type-I diabetes
The recovery from inactivation of It in rat model
formulations is biphasic in nature, consisting of fast and
slow components (Pandit et al., 2001). This is in accordance
with experimental observations (Shimoni et al., 1995). The
contribution of the slow component to overall inactivation is
11% in the control case, and is enhanced to 31% in the
diabetic case. By incorporating the experimentally described
slowed recovery in It (Shimoni et al., 1994), the model is
able to simulate the enhanced prolongation of APD when
stimulus frequency was increased from 0.5 Hz to 2.0 Hz
under diabetic conditions, compared with the control one
(Fig. 3). Interestingly, the fast and slow inactivation var-
iables in the model formulation for It have been deemed to
represent the contributions of Kv4.2/Kv4.3 and Kv1.4 to It
respectively (Pandit et al., 2001). The greater contribution
of the slower inactivation variable in the diabetic model is
in accordance with very recent experimental observations
demonstrating that the density of Kv1.4 is substantially en-
hanced in diabetic conditions (Nishiyama et al., 2001).
Our model also predicts a small decrease (5%) in the
upstroke of the diabetic action potential, which has been
experimentally observed (Pacher et al., 1999). Our simu-
lations show that the underlying cause for this decrease is the
reduction in the availability of the Naþ channels, due to the
small depolarization of Vrest. Specifically, the steady-state,
half-inactivation voltage of INa is 76.1 mV; therefore even
a small depolarization (0.5–1.0 mV) in Vrest can change the
Naþ channel availability. Indeed, experimental evidence
shows that there is a decrease in the maximum rate of
depolarization in STZ-induced diabetic rats, which increases
progressively with development of the disease (Pacher et al.,
1999). The lack of any significant change in the peak
overshoot of the diabetic action potential, when compared to
the control one can be explained by a reduction in INa, in
combination with a simultaneous reduction in It. Again, this
finding is in accordance with experimental findings, where
no significant differences were found in peak overshoot
values during chronic diabetes (Casis et al., 2000).
From our quantitative analysis, we note that a small
depolarization in Vrest (and the subsequent change in Rin)
can be attributed primarily to a downregulation of the
electrogenic pump current, INaK. Thus, the model is able to
replicate the tendency toward depolarization in diabetic
myocytes (Shimoni et al., 1994). Interestingly, Vrest is also
reported to differ significantly in myocytes maintained under
hyperglycemic conditions (Ren et al., 1997). Vrest was
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77.061.0 mV under high glucose conditions, compared
to 81.061.0 mV in normal conditions (Ren et al., 1997).
Reported effects of PKC can be integrated
into this model
Several investigators have provided strong evidence that the
subcellular changes in the diabetic heart may be partially due
to alterations in the protein kinase C (PKC) activity, and/or
PKC-mediated signal transduction mechanisms. In particu-
lar, the translocation of ePKC from cystolic to particulate
fractions has been described in diabetic myocytes (Koya and
King, 1998; Liu et al., 1999). The functional activation of
ePKC has been observed in the in vivo, STZ-induced model
of diabetes (Malhotra et al., 1997), as well as in myocytes
maintained under hyperglycemic conditions (Malhotra et al.,
2001). Accordingly, our simulations have incorporated the
experimentally observed effects of ePKC on ICaL (Hu et al.,
2000) and INaK (Buhagiar et al., 2001), because the al-
terations in these currents have not been measured in myo-
cytes isolated from the short-term, in vivo, diabetic model.
These changes were necessary in our overall explanation
for the abnormal Ca2þ homeostasis and changes in Vrest
observed in the diabetic myocyte experimentally (Shimoni
et al., 1994).
The activation of ePKC in hyperglycemic conditions also
increases the phosphorylation of troponin I (Malhotra et al.,
2001), and cardiac specific over-expression of ePKC is
known to increase the myofilament sensitivity to Ca2þ ions
(Takeishi et al., 2000). Additionally, it has been shown that
PKC activation slows inactivation of INa, which affects the
APD90 value in rat ventricular myocytes (Ward and Giles,
1997). However it is unclear at the present time whether this
mechanism contributes to an APD prolongation in diabetes.
Accordingly, these and other reported effects of PKC
isoform-specific activation have not been included in the
present model formulations. However, they suggest that the
contribution of additional ionic mechanisms/biophysical
processes to the diabetic phenotype cannot be ruled out.
Limitations
These results and insights from rat ventricular myocytes
under diabetic conditions should be extrapolated with
caution when attempting to relate them to similar human
studies, because the ventricular action potential and the
underlying ionic currents are very different in humans and
rats. A second limitation of the present study is that the SR
Ca2þ dynamics have been adapted from a canine common
pool model (Winslow et al., 1999). The Ca2þ dynamics in rat
are now known to be different from their canine counterparts
(Bers, 2001). Future modifications that incorporate and
validate the model for the specific properties in rat, as well as
formulations for a more sophisticated local control model of
the Ca2þ dynamics will be essential to simulate [Ca2þ]i
homeostasis and mechanisms such as graded SR release
(Greenstein and Winslow, 2001). A third limitation is that
the present model does not account for the changes in the
intracellular Naþ concentration ([Naþ]i), which might occur
during prolonged periods of pacing (the present simulation
results are illustrated after a train of 20 pulses). Experimental
studies have reported both an increase in [Naþ]i (Warley,
1991), and a decrease in [Naþ]i (Katoh et al., 1995) during
diabetes; thus this important issue remains controversial. Our
model also does not incorporate a formulation for the Naþ-
Hþ exchanger, which is an important mediator of Naþ ion
influx in rat ventricular myocytes (Despa et al., 2002), and is
depressed during diabetes (Pierce et al., 1990). In summary,
both experimental ambiguities and modeling limitations
prevent the present study from accounting for the changes in
[Naþ]i during long-term pacing. Finally, we note that the
changes in ICaL and SR activity in the diabetic model are
FIGURE 7 Diagram summarizing the electrophysiological alterations and
their underlying causes as revealed by this mathematical model in the setting
of short-term, type-I (insulin dependent), STZ-induced diabetes in rat
ventricular myocytes.
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based on observations in cultured myocytes and chronic
diabetic conditions respectively, because corresponding data
from the short-term, STZ-induced model of diabetes in rat
are not available. Further experiments are therefore neces-
sary to obtain quantitative data regarding the changes in the
intracellular Ca2þ dynamics under well-defined type-I
diabetic conditions. Thereafter, this aspect of the present
modeling effort can and should be improved and updated.
SUMMARY
The results of this model development provide novel insights
into the plausible ionic mechanisms that can account for the
changes in the action potential profile and the abnormal
excitation-contraction coupling in rat ventricular myocytes
induced with type-I diabetes. APD prolongation is due to
a reduction of the Kþ currents It and Iss, along with slowed
inactivation of ICaL. The abnormal Ca2þ homeostasis
(smaller peak, reduced rate of decay) can be attributed to
a decreased SR load, which results from a combination of
a downregulation in ICaL and an impaired SR uptake. The
small depolarization of the resting membrane potential (Vrest)
is due to a decrease in the Naþ-Kþ pump current. The change
in Vrest reduces the availability of the Naþ channels, causing
a slower upstroke of the action potential (dV/dtmax). These
interacting factors are summarized in Fig. 7, which in
diagram form present the interdependent biophysical mech-
anisms for the observed electrophysiological changes, and in
that way, highlight potential targets for reversing the diabetic
cellular phenotype by means of gene therapy approaches
(Trost et al., 2002). A future interesting extension of this
study could involve exploring the action potential variations
in the rat left ventricle during diabetes and predicting the
subsequent changes in T-wave shape, and could be based on
a recent modeling study (Gima and Rudy, 2002).
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